Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Adam T Waickman, Krista Newell, Timothy P Endy & Stephen J Thomas. (2023) Biologics for dengue prevention: up-to-date. Expert Opinion on Biological Therapy 23:1, pages 73-87.
Read now
Read now
Vivak Parkash, Paul M. Kaye, Alison M Layton & Charles J Lacey. (2021) Vaccines against leishmaniasis: using controlled human infection models to accelerate development. Expert Review of Vaccines 20:11, pages 1407-1418.
Read now
Read now
Philippe Moris, Kristen M. Bauer, Jeffrey R. Currier, Heather Friberg, Kenneth H. Eckels, Ines O. Esquilin, Robert V. Gibbons, Bruce L. Innis, Richard G. Jarman, Sriluck Simasathien, Peifang Sun, Stephen J. Thomas & Veerachai Watanaveeradej. (2019) Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions. Human Vaccines & Immunotherapeutics 15:9, pages 2090-2105.
Read now
Read now
Hemalatha Beesetti, Navin Khanna & Sathyamangalam Swaminathan. (2016) Investigational drugs in early development for treating dengue infection. Expert Opinion on Investigational Drugs 25:9, pages 1059-1069.
Read now
Read now
Anon Srikiatkhachorn & In-Kyu Yoon. (2016) Immune correlates for dengue vaccine development. Expert Review of Vaccines 15:4, pages 455-465.
Read now
Read now
Denice Spero & Lauren Levitz. (2013) Report from the field. Human Vaccines & Immunotherapeutics 9:7, pages 1555-1557.
Read now
Read now
Articles from other publishers (28)
Eng Eong Ooi & Shirin Kalimuddin. (2023) Insights into dengue immunity from vaccine trials. Science Translational Medicine 15:704.
Crossref
Crossref
Scott B. Halstead & David W. Vaughn. 2023. Plotkin's Vaccines. Plotkin's Vaccines
275
285.e6
.
Stephen J. Thomas, Timothy P. Endy & Alan L. Rothman. 2020. Viral Infections of Humans. Viral Infections of Humans
1
65
.
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets & Jorge Flores. (2022) Controlled Human Infection Models To Accelerate Vaccine Development. Clinical Microbiology Reviews 35:3.
Crossref
Crossref
Timothy P Endy, Dongliang Wang, Mark E Polhemus, Richard G Jarman, Louis E Jasper, Greg Gromowski, Leyi Lin, Rafael A De La Barra, Heather Friberg, Jeffrey R Currier, Mark Abbott, Lisa Ware, Michelle Klick, Kristopher M Paolino, Donald C Blair, Kenneth Eckels, Wiriya Rutvisuttinunt & Stephen J Thomas. (2021) A Phase 1, Open-Label Assessment of a Dengue Virus-1 Live Virus Human Challenge Strain. The Journal of Infectious Diseases 223:2, pages 258-267.
Crossref
Crossref
Euzebiusz Jamrozik & Michael J. SelgelidEuzebiusz Jamrozik & Michael J. Selgelid. 2021. Human Challenge Studies in Endemic Settings. Human Challenge Studies in Endemic Settings
25
82
.
Kulkanya Chokephaibulkit, Yu-Wen Chien, Sazaly AbuBakar, Kovit Pattanapanyasat & Guey Chuen Perng. (2020) Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development. Viruses 12:11, pages 1261.
Crossref
Crossref
Christine A. King, Adam D. Wegman & Timothy P. Endy. (2020) Mobilization and Activation of the Innate Immune Response to Dengue Virus. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Bruno Guy, Eng Eong Ooi, Jose Ramos-Castañeda & Stephen J. Thomas. (2020) When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?. Vaccines 8:2, pages 174.
Crossref
Crossref
Scott B. Halstead. (2018) Insights from direct studies on human dengue infections. Proceedings of the National Academy of Sciences 116:1, pages 17-19.
Crossref
Crossref
Kathryn B Anderson, Timothy P Endy & Stephen J Thomas. (2018) The dynamic role of dengue cross-reactive immunity: changing the approach to defining vaccine safety and efficacy. The Lancet Infectious Diseases 18:10, pages e333-e338.
Crossref
Crossref
Bouchra Kitab, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2018) Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections. Archives of Virology 163:7, pages 1717-1726.
Crossref
Crossref
Scott B. Halstead & Stephen J. Thomas. 2018. Plotkin's Vaccines. Plotkin's Vaccines
241
251.e6
.
Irfan A. Rather, Hilal A. Parray, Jameel B. Lone, Woon K. Paek, Jeongheui Lim, Vivek K. Bajpai & Yong-Ha Park. (2017) Prevention and Control Strategies to Counter Dengue Virus Infection. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Crossref
Suzanne JF Kaptein & Johan Neyts. (2016) Towards antiviral therapies for treating dengue virus infections. Current Opinion in Pharmacology 30, pages 1-7.
Crossref
Crossref
Bruno GuyJean LangMelanie SavilleNicholas Jackson. (2016) Vaccination Against Dengue: Challenges and Current Developments. Annual Review of Medicine 67:1, pages 387-404.
Crossref
Crossref
Bruno Guy, Olivier Briand, Jean Lang, Melanie Saville & Nicholas Jackson. (2015) Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward. Vaccine 33:50, pages 7100-7111.
Crossref
Crossref
Kitti Wing Ki Chan, Satoru Watanabe, Ranmali Kavishna, Sylvie Alonso & Subhash G. Vasudevan. (2015) Animal models for studying dengue pathogenesis and therapy. Antiviral Research 123, pages 5-14.
Crossref
Crossref
David L. Evers, Carol B. Fowler, Jeffrey T. Mason & Rebecca K. Mimnall. (2014) Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects. Science and Engineering Ethics 21:4, pages 1049-1064.
Crossref
Crossref
Louis Lambrechts, Neil M Ferguson, Eva Harris, Edward C Holmes, Elizabeth A McGraw, Scott L O'Neill, Eng E Ooi, Scott A Ritchie, Peter A Ryan, Thomas W Scott, Cameron P Simmons & Scott C Weaver. (2015) Assessing the epidemiological effect of wolbachia for dengue control. The Lancet Infectious Diseases 15:7, pages 862-866.
Crossref
Crossref
Thomas C Darton, Christoph J Blohmke, Vasee S Moorthy, Daniel M Altmann, Frederick G Hayden, Elizabeth A Clutterbuck, Myron M Levine, Adrian V S Hill & Andrew J Pollard. (2015) Design, recruitment, and microbiological considerations in human challenge studies. The Lancet Infectious Diseases 15:7, pages 840-851.
Crossref
Crossref
Eng Eong Ooi, Benjamin Haaland, Duane J. Gubler & Grace E. Snow. (2014) Research on Dengue During World War II Revisited. The American Journal of Tropical Medicine and Hygiene 91:6, pages 1203-1217.
Crossref
Crossref
James Whitehorn, Sophie Yacoub, Katherine L. Anders, Louis R. Macareo, M. Cristina Cassetti, Vinh Chau Nguyen Van, Pei-Yong Shi, Bridget Wills & Cameron P. Simmons. (2014) Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future Directions. PLoS Neglected Tropical Diseases 8:8, pages e3025.
Crossref
Crossref
A. L. Rothman. (2014) DHIM Supporting Immunologic Investigations and the Identification of Immune Correlates of Protection. Journal of Infectious Diseases 209:suppl 2, pages S61-S65.
Crossref
Crossref
C. N. Mores, R. C. Christofferson & S. A. Davidson. (2014) The Role of the Mosquito in a Dengue Human Infection Model. Journal of Infectious Diseases 209:suppl 2, pages S71-S78.
Crossref
Crossref
Mark K. Slifka. (2014) Vaccine-Mediated Immunity Against Dengue and the Potential for Long-Term Protection Against Disease. Frontiers in Immunology 5.
Crossref
Crossref
M. Cristina Cassetti & Scott B. Halstead. (2014) Consultation on dengue vaccines: Progress in understanding protection, 26?28 June 2013, Rockville, Maryland. Vaccine 32:26, pages 3115-3121.
Crossref
Crossref
Stephen J. Thomas, Timothy P. Endy & Alan L. Rothman. 2014. Viral Infections of Humans. Viral Infections of Humans
351
381
.